ABT

Abbott Laboratories Price

ABT
$101,83
-$0,47(-%0,45)

*Data last updated: 2026-04-07 23:06 (UTC+8)

As of 2026-04-07 23:06, Abbott Laboratories (ABT) is priced at $101,83, with a total market cap of $176,93B, a P/E ratio of 33,55, and a dividend yield of %2,35. Today, the stock price fluctuated between $101,42 and $102,86. The current price is %0,40 above the day's low and %1,00 below the day's high, with a trading volume of 6,34M. Over the past 52 weeks, ABT has traded between $100,88 to $139,06, and the current price is -%26,77 away from the 52-week high.

ABT Key Stats

Yesterday's Close$102,30
Market Cap$176,93B
Volume6,34M
P/E Ratio33,55
Dividend Yield (TTM)%2,35
Dividend Amount$0,63
Diluted EPS (TTM)3,73
Net Income (FY)$6,52B
Revenue (FY)$44,32B
Earnings Date2026-04-16
EPS Estimate1,14
Revenue Estimate$11,00B
Shares Outstanding1,72B
Beta (1Y)0.782
Ex-Dividend Date2026-04-15
Dividend Payment Date2026-05-15

About ABT

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
SectorHealthcare
IndustryMedical - Devices
CEORobert Ford
HeadquartersAbbott Park,IL,US
Official Websitehttps://www.abbott.com
Employees (FY)115,00K
Average Revenue (1Y)$385,46K
Net Income per Employee$56,73K

Learn More about Abbott Laboratories (ABT)

Abbott Laboratories (ABT) FAQ

What's the stock price of Abbott Laboratories (ABT) today?

x
Abbott Laboratories (ABT) is currently trading at $101,83, with a 24h change of -%0,45. The 52-week trading range is $100,88–$139,06.

What are the 52-week high and low prices for Abbott Laboratories (ABT)?

x

What is the price-to-earnings (P/E) ratio of Abbott Laboratories (ABT)? What does it indicate?

x

What is the market cap of Abbott Laboratories (ABT)?

x

What is the most recent quarterly earnings per share (EPS) for Abbott Laboratories (ABT)?

x

Should you buy or sell Abbott Laboratories (ABT) now?

x

What factors can affect the stock price of Abbott Laboratories (ABT)?

x

How to buy Abbott Laboratories (ABT) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Hot Posts About Abbott Laboratories (ABT)